About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 4534 record(s)
Req # A-2020-001670
Adverse Reaction Report (AERs) for Naltrexone. Report number: 000921857 (ADRs) for Hydromorphone. Report numbers: 914621, 918738. (ADR) for Heparin. Report number: E2B_02830812.Organization: Health Canada
April 2021
Req # A-2020-001677
Adverse Drug Reaction (ADR) for METRONIDAZOLE. Report number: E2B_01198405.Organization: Health Canada
April 2021
Req # A-2020-001689
Adverse Reaction Reports (AERs) for Diclectin (doxylamine succinate / pyridoxine hydrochloride). Report numbers: 000925695, 000925698, 000925727, 000925952, E2B_03296221.Organization: Health Canada
April 2021
Req # A-2020-001763
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03473172.Organization: Health Canada
April 2021
Req # A-2020-001896
Adverse Reaction Reports (AERs) for Mifegymiso. Report numbers: 000924450, 000931171. (ADR) for Misoprostol. Report number: 000931875.Organization: Health Canada
April 2021
Req # A-2021-000006
Adverse Reaction Reports (AERs) for Keytruda. Report numbers: 000700874, 000701307, 000702256, 000702349, 000705041, 000705329, 000705536, 000705565, 000706160.Organization: Health Canada
April 2021
Req # A-2021-000013
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_00476395.Organization: Health Canada
April 2021
Req # A-2021-000020
Adverse Drug Reaction (ADR). Report number: 000929307.Organization: Health Canada
April 2021
Req # A-2021-000031
Adverse Reaction Reports (AERs). Report numbers: 000925559, 000926151, 000924858.Organization: Health Canada
April 2021
Req # A-2020-00147
Request in regard to the revocation of the decision TB7-1985-1 as a jurisprudential guide 1. Any relevant records, memoranda, notes, briefing documents, and communication including but not limited to correspondences, e-mail, and faxes between the…Organization: Immigration and Refugee Board of Canada
April 2021